Recruiting

Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease

For the first time, this study developed an anti-inflammatory diet （AID） recipe suitable for Inflammatory bowel disease（IBD） patients and developed an AID application program to verify the intervention effect of AID on IBD patients, which not only promoted the application of AID in IBD patients and promoted the promotion of AID model, but also provided new ideas for the prevention and treatment strategies for IBD patients.

ClinicalTrials.gov IDNCT06342011

PhaseNA

Enrollment88

SponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Inflammatory Bowel Diseases

About this study

Interventions

Behavioral: Anti-inflammatory diet group — Patients in the intervention group were given AID knowledge education, and patients were asked to pay attention to the "anti-inflammatory diet" wechat mini program developed by the researchers to teach patients how to use it, including the selection of anti-inflammatory diet, unsuitable anti-inflammatory diet, diet alarm clock, diet notes and other related functions. The missionary patients insisted on AID until reexamination 8 weeks later.

Primary outcomes

C-reactive protein (8 weeks after intervention)
Erythrocyte sedimentation rate (ESR) (8 weeks after intervention)
Leukocyte (8 weeks after intervention)

Eligibility information

Inclusion Criteria: 1. Diagnosis of inflammatory bowel disease, the diagnostic criteria refer to the 2018 revised Consensus opinion on the diagnosis and treatment of inflammatory bowel disease; 2. The patient has clear consciousness and certain understanding, language expression and writing ability; 3. Patients participated in this study knowingly and voluntarily; 4. At least 18 years old. Exclusion Criteria: 1. cognitive impairment, mental illness, accompanied by mental disorders; 2. Alcohol and drug abusers. 3. The patient could not participate in the researcher due to the deterioration of the condition; 4. Patients who voluntarily quit due to other reasons; 5. Those who did not complete the assessment scale during the experiment.

Study locations

The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang 322000 China

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.